To amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the supply chain transparency needed for companies to make safe cosmetics, and for other purposes.
Sponsors
Legislative Progress
IntroducedMs. Schakowsky (for herself, Mrs. Dingell, Mr. Evans of Pennsylvania, …
Summary
What This Bill Does
The Cosmetic Supply Chain Transparency Act of 2025 amends the Federal Food, Drug, and Cosmetic Act to require cosmetic companies to have full visibility into their supply chains. Key provisions include mandatory ingredient disclosure, FDA nonfunctional constituent list, testing requirements, traceability, and state preemption limits.
Who Benefits and How
- Consumers: Gain access to safer cosmetics through mandatory testing for harmful chemicals
- Brand owners: Can demand full ingredient disclosure from suppliers
- States with strong cosmetic regulations: Preserved from federal preemption
- Public health groups: Advisory committee participation
Who Bears the Burden and How
- Cosmetic ingredient suppliers: Must disclose full formulations, provide safety documentation, conduct testing
- Fragrance and flavor companies: Must reveal proprietary formulations
- Cosmetic manufacturers: Must maintain supply chain records
Key Provisions
- Section 621: Defines key terms
- Section 622: Mandates 90-day disclosure requirements
- Section 623: FDA process for harmful constituent list
- Section 624: Testing and certificate requirements
- Section 625: Traceability requirements
- Section 626: Civil penalties up to USD 10,000/day
Evidence Chain:
This summary is derived from the structured analysis below. See "Detailed Analysis" for per-title beneficiaries/burden bearers with clause-level evidence links.
Primary Purpose
Establish cosmetic supply chain transparency requirements by mandating disclosure of ingredient information, creating FDA list of harmful nonfunctional constituents, requiring testing and certification, and enabling supply chain traceability for adulterated or misbranded cosmetics.
Policy Domains
Legislative Strategy
"Leverages existing regulatory frameworks (California Prop 65, EU REACH, WHO IARC) to define harmful substances"
Likely Beneficiaries
- Consumers seeking safer cosmetics
- Large brand owners
- States with strong cosmetic regulations
- Public health organizations
Likely Burden Bearers
- Fragrance and flavor companies
- Small ingredient suppliers
- Cosmetic manufacturers
- Foreign suppliers
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "supplier"
- → Entity supplying cosmetic, packaging, ingredient, or raw material
- "brand owner"
- → Entity responsible for bringing a cosmetic to market
- "manufacturer"
- → Entity that produces an ingredient or combines ingredients
- "The Secretary"
- → Secretary of Health and Human Services (FDA)
Key Definitions
Terms defined in this bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology